1. Tracking binding modes of 1,2,4-trisubstituted imidazolinone P38 MAP kinase and ERK-2 inhibitors
    Shashidhar N. Rao, 2017, Journal of Molecular Graphics and Modelling CrossRef
  2. Resveratrol and cancer treatment: updates.
    Zhengdong Jiang et al, 2017, Ann N Y Acad Sci CrossRef
  3. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment.
    Shireen Chikara et al, 2018, Cancer Lett CrossRef
  4. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines
    A. Carlson et al, 2017, Vet Comp Oncol CrossRef
  5. Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
    Ammad Farooqi et al, 2018, IJMS CrossRef
  6. Potential mechanisms of action of dietary phytochemicals for cancer prevention by targeting cellular signaling transduction pathways
    HONGYU CHEN et al, 2018, J. Agric. Food Chem. CrossRef
  7. Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.
    Liang Cheng et al, 2018, Oxid Med Cell Longev CrossRef
  8. Hydroxystilbenes and methoxystilbenes activate human aryl hydrocarbon receptor and induce CYP1A genes in human hepatoma cells and human hepatocytes
    Barbora Pastorková et al, 2017, Food and Chemical Toxicology CrossRef
  9. Hesperetin inhibits Eca-109 cell proliferation and invasion by suppressing the PI3K/AKT signaling pathway and synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal cancer in vitro and in vivo
    Dandan Wu et al, 2018, RSC Adv. CrossRef
  10. Resveratrol inhibits Erk1/2-mediated adhesion of cancer cells via activating PP2A-PTEN signaling network
    Xin Chen et al, 2018, J Cell Physiol CrossRef
  11. Inhibitory Effect of Anoectochilus formosanus Extract on Hyperglycemia-Related PD-L1 Expression and Cancer Proliferation
    Yih Ho et al, 2018, Front. Pharmacol. CrossRef
  12. Inhibiting ROS-NF-κB-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma
    Zhi-Jing He et al, 2017, Food and Chemical Toxicology CrossRef
  13. Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats
    Chang-He Liu et al, 2018, BMC Cardiovasc Disord CrossRef
  14. Acquired Resilience: An Evolved System of Tissue Protection in Mammals
    Jonathan Stone et al, 2018, Dose-Response CrossRef
  15. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3
    Bulbul Ahmmed et al, 2019, J Cell Physiol CrossRef
  16. Reciprocal interaction of HOTAIR and SP1 together enhance the ability of Xiaoji decoction and gefitinib to inhibit EP4 expression
    Jingjing Wu et al, 2019, Journal of Ethnopharmacology CrossRef
  17. Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice
    Yuxin Xian et al, 2019, Diabetes Research and Clinical Practice CrossRef
  18. Effects of hyperglycemia on the progression of tumor diseases
    Wenjie Li et al, 2019, J Exp Clin Cancer Res CrossRef
  19. Oxyresveratrol activates parallel apoptotic and autophagic cell death pathways in neuroblastoma cells
    Md. Ataur Rahman et al, 2017, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  20. Emerging Perspective: Role of Increased ROS and Redox Imbalance in Skin Carcinogenesis
    Dehai Xian et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  21. Pancreatic cancer resistance to chemotherapy
    Begum Dariya et al, 2019 CrossRef

  22. Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11


    Changjie Lin et al, 2020, OTT CrossRef
  23. Resveratrol in Cancer Patients: From Bench to Bedside
    Massimiliano Berretta et al, 2020, IJMS CrossRef
  24. Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation
    Weikun Qian et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  25. Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway
    Xumin Zhou et al, 2020, Front. Pharmacol. CrossRef
  26. Polyphenols as Possible Agents for Pancreatic Diseases
    Uroš Gašić et al, 2020, Antioxidants CrossRef
  27. The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy
    Chen Wang et al, 2019, Exp Ther Med CrossRef
  28. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway
    Liu Yang et al, 2019, Mol Med Report CrossRef
  29. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1
    Yuan Li et al, 2018, Int J Oncol CrossRef
  30. NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer
    Tao Qin et al, 2020, Front. Oncol. CrossRef
  31. Dietary Polyphenols in Cancer Chemoprevention: Implications in Pancreatic Cancer
    Anita Thyagarajan et al, 2020, Antioxidants CrossRef
  32. Chitosan derived nitrogen-doped carbon dots suppress osteoclastic osteolysis via downregulating ROS
    Runfeng Chen et al, 2020, Nanoscale CrossRef
  33. Rosmarinic acid inhibits migration, invasion, and p38/AP-1 signaling via miR-1225-5p in colorectal cancer cells
    Kaiyan Yang et al, 2020, Journal of Receptors and Signal Transduction CrossRef
  34. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review
    Yue Gao et al, 2020, Phytotherapy Research CrossRef
  35. High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
    Unchalee Thonsri et al, 2020, Cancer Sci CrossRef
  36. Anti-Inflammatory Action and Mechanisms of Resveratrol.
    Tiantian Meng et al, 2021, Molecules CrossRef
  37. Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
    Aranka Brockmueller et al, 2021, Cancers CrossRef
  38. Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
    Kaibo Guo et al, 2021, Front. Oncol. CrossRef
  39. High glucose: an emerging association between diabetes mellitus and cancer progression
    Suangson Supabphol et al, 2021, J Mol Med CrossRef
  40. Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development
    Xiaoye Duan et al, 2021, Front. Oncol. CrossRef
  41. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
    Peng Yuan et al, 2021, Mol Med Rep CrossRef
  42. Hyperglycaemia‐induced human hepatocellular carcinoma (HepG2) cell proliferation through ROS‐mediated P38 activation is effectively inhibited by a xanthophyll carotenoid, lutein
    Tehreem Maradagi et al, 2021, Diabet Med CrossRef
  43. Targeting the Redox Imbalance in Mitochondria: A revolutionary mode for cancer therapy
    Shalini Mani et al, 2021, Mitochondrion CrossRef
  44. Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
    Andrea De Pieri et al, 2022, Pharmaceutics CrossRef
  45. Applications of resveratrol in the treatment of gastrointestinal cancer
    Mohammad Roshani et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  46. Surgical Stress and Cancer Progression: New Findings and Future Perspectives
    Yanghanzhao Wang et al, 2022, Curr Oncol Rep CrossRef
  47. Bisphenol A Promotes the Progression of Colon Cancer Through Dual-Targeting of NADPH Oxidase and Mitochondrial Electron-Transport Chain to Produce ROS and Activating HIF-1α/VEGF/PI3K/AKT Axis
    Tianyi Xia et al, 2022, Front. Endocrinol. CrossRef
  48. Oxidatively damaged nucleic acid: Linking diabetes and cancer
    Xiujuan Hong et al, 2022, Antioxidants & Redox Signaling CrossRef
  49. High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway
    Junyuan Deng et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  50. The Adipocyte–Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy
    Sofía Sanhueza et al, 2023, Antioxidants CrossRef
  51. RNA methylation and cellular response to oxidative stress-promoting anticancer agents
    Marco Ponzetti et al, 2023, Cell Cycle CrossRef
  52. Resveratrol Effects on Molecular Pathways and MicroRNAs in Gastrointestinal Cancers
    Amirhossein Davoodvandi et al, 2023, CMC CrossRef
  53. Mechanism of the Anti-cancer Action of Natural Dietary Compounds
    Ching-Shu Lai et al, 2023 CrossRef
  54. Advances in the treatment of pancreatic cancer with traditional Chinese medicine
    Yanhua Zhang et al, 2023, Front. Pharmacol. CrossRef
  55. Inhibition of autophagy enhances the anticancer effect of Schisandrin B on head and neck squamous cell carcinoma
    Mengmeng Li et al, 2023, J Biochem & Molecular Tox CrossRef
  56. Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects
    Nicolette Casarcia et al, 2023, British J Pharmacology CrossRef
  57. Biocompatible polymeric nanoparticles as carriers for critical anticancer phytochemicals
    Malsawmdawngkima Hnamte et al, 2023, European Polymer Journal CrossRef
  58. From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation
    Shuhan Yang et al, 2024, Front. Cell. Infect. Microbiol. CrossRef
  59. Drug Delivery Systems for Intervertebral Disc
    Isma Liza Mohd Isa et al, 2024 CrossRef
  60. Protective effect of resveratrol on nickel-refining fumes-induced inflammatory damage
    Yu-Lin Pan et al, 2024, Cell Biochem Biophys CrossRef
  61. Resveratrol activates MAPK/ERK pathway to regulate oestrogen metabolism in type I endometrial cancer
    Qing Wang et al, 2024, BMC Complement Med Ther CrossRef
  62. ROLE OF REACTIVE OXYGEN SPECIES IN CARCINOGENESIS AND POLYPHENOLS AS AN EMERGING THERAPEUTIC INTERVENTION
    Aparajita Das et al, 2024 CrossRef
  63. Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action
    Wamidh H. Talib et al, 2024, IJMS CrossRef
  64. Triosephosphate Isomerase Inhibition by Resveratrol: A New Mechanism of Anti-Glycolysis in Breast Cancer
    G. Tuna et al, 2024, Mol Biol CrossRef
  65. Promising potential effects of resveratrol on oral and dental health maintenance: a comprehensive review
    Shirin Zahra Farhad et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  66. A review of the last decade: pancreatic cancer and type 2 diabetes
    Jiaqi Wu et al, 2024, Archives of Physiology and Biochemistry CrossRef